Skip to main content
RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc. — Investor Relations & Filings

Ticker · RAPT ISIN · US75382E1091 LEI · 549300MB473BIU78ES48 US Manufacturing
Filings indexed 534 across all filing types
Latest filing 2020-01-28 Capital/Financing Update
Country US United States of America
Listing US RAPT

About RAPT Therapeutics, Inc.

https://rapt.com/

RAPT Therapeutics, Inc. is a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for patients with inflammatory and immunologic diseases. The company's scientific approach involves developing therapeutics that intelligently target key drivers of the immune system. Its pipeline includes ozureprubart (RPT904), a long-acting anti-IgE antibody being evaluated in a Phase 2b clinical trial for the treatment of food allergies.

Recent filings

Filing Released Lang Actions
Capital/Financing Update 2020
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC by RAPT Therapeutics, Inc. It is a registration statement under the Securities Act of 1933, used for registering securities for public offering. The text includes detailed information about the company, the offering, risk factors, management discussion, financial data, and other disclosures typical of an S-1 filing. This is not an annual or quarterly report, earnings release, or any other report type listed. It is a capital markets filing related to the company's initial or follow-on public offering. According to the filing definitions, updates on company fundraising or financing activities fall under Capital/Financing Update (CAP). Therefore, this document should be classified as a Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement, not just an announcement, so it is not RPA or RNS. Confidence is high given the clear identification of the form and content.
2020-01-28 English
FORM 5 SUBMISSION
Director's Dealing
2020-01-18 English
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated January 9, 2020, by RAPT Therapeutics, Inc. The key content is the filing of an investor presentation (Corporate Presentation) as Exhibit 99.1. The text explicitly states that the presentation is attached and may be used in conversations with investors and analysts. There are no financial statements or detailed financial data included in the text itself, only a reference to the presentation. The document length is 3413 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, when a document is short and primarily announces or attaches a presentation, it should be classified as an Investor Presentation (IP).
2020-01-09 English
10-Q
Interim / Quarterly Report Q3 2019
2019-12-11 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the company issued a press release announcing its financial results for the quarter ended September 30, 2019, and that the press release is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release. The length of the document is 3683 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document that announces or furnishes a press release of financial results without containing the full financial data should be classified as a Regulatory Filing (RNS), as it does not meet the criteria for an Earnings Release (ER) or Interim Report (IR) itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2019-12-11 English
FORM 4 SUBMISSION
Director's Dealing
2019-12-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.